menu
    • menu

    Company profile for dMed Biopharmaceutical

    Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

    Virtual Booth

    Contact Supplier

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Willow Birch Pharma delivers trusted, high-quality APIs nationwide with unmatched service, compliance, and competitive value.

    Virtual Booth

    Contact Supplier

    AMI Lifesciences is Driven by Chemistry. Powered by People.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    The Chinese pharma industry has reached a historic turning point in the era of innovation, filled with opportunities & challenges. Clinical trials must be implemented in accordance with international standards at the highest quality. dMed Biopharmaceutical Company Limited is a clinical Contract Research Organization (CRO), providing high-end services to innovative biopharmaceutical and medical device companies. dMed is committ...
    The Chinese pharma industry has reached a historic turning point in the era of innovation, filled with opportunities & challenges. Clinical trials must be implemented in accordance with international standards at the highest quality. dMed Biopharmaceutical Company Limited is a clinical Contract Research Organization (CRO), providing high-end services to innovative biopharmaceutical and medical device companies. dMed is committed to increasing the probability of success of R&D products. Its services include Consulting, Clinical Operations, Biostatistics & Programming, Data Management, Pharmacovigilance, Clinical Science & Medical Affairs.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    dMed BiopharmaceuticalChina Flag
    Country
    Country
    China
    Address
    Address
    298 Xiangke Road, 3/F, 301-305，Zhangjiang Hi-Tech Park, Pudong, Shanghai 201...
    Telephone
    Telephone
    +86 21 5090 0085
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.dmedglobal.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/dmedglobal
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    dMed Adjourns Annual General Meeting of Shareholders
    dMed Adjourns Annual General Meeting of Shareholders

    15 Jun 2023

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20230615304050/en

    BUSINESSWIRE
    15 Jun 2023
    Share Share
    dMed-Clinipace Announces Completion of US$50 Million Series C+ Financing
    dMed-Clinipace Announces Completion of US$50 Million Series C+ Financing

    07 Jul 2021

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/dmed-clinipace-announces-completion-of-us50-million-series-c-financing-from-new-investors-301326776.html

    PR NEWSWIRE
    07 Jul 2021
    Share Share
    dMed Completed a US$100 Million Series C Financing
    dMed Completed a US$100 Million Series C Financing

    17 Dec 2020

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/dmed-completed-a-us100-million-series-c-financing-301194727.html

    PRNEWSWIRE
    17 Dec 2020
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search